The primary objectives of the present study were to answer 2 questions: a) Is VIP effective in preventing and reversing a model of PAH, such as that induced by MCT, which is both widely used and not directly attributable to VIP deficiency? This evidence concerns the gene VIP and hyperinsulinemic hypoglycemia, familial, 4.